22-50675077-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_ModerateBP7BS2

The NM_001372044.2(SHANK3):​c.318C>T​(p.Pro106Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000359 in 1,392,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. P106P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

SHANK3
NM_001372044.2 synonymous

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.77

Publications

0 publications found
Variant links:
Genes affected
SHANK3 (HGNC:14294): (SH3 and multiple ankyrin repeat domains 3) This gene is a member of the Shank gene family. Shank proteins are multidomain scaffold proteins of the postsynaptic density that connect neurotransmitter receptors, ion channels, and other membrane proteins to the actin cytoskeleton and G-protein-coupled signaling pathways. Shank proteins also play a role in synapse formation and dendritic spine maturation. Mutations in this gene are a cause of autism spectrum disorder (ASD), which is characterized by impairments in social interaction and communication, and restricted behavioral patterns and interests. Mutations in this gene also cause schizophrenia type 15, and are a major causative factor in the neurological symptoms of 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome. Additional isoforms have been described for this gene but they have not yet been experimentally verified. [provided by RefSeq, Mar 2012]
SHANK3 Gene-Disease associations (from GenCC):
  • Phelan-McDermid syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Laboratory for Molecular Medicine
  • schizophrenia 15
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP7
Synonymous conserved (PhyloP=-1.77 with no splicing effect.
BS2
High AC in GnomAdExome4 at 5 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001372044.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK3
NM_001372044.2
MANE Select
c.318C>Tp.Pro106Pro
synonymous
Exon 4 of 25NP_001358973.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK3
ENST00000692848.2
c.318C>Tp.Pro106Pro
synonymous
Exon 3 of 23ENSP00000510794.2A0A8I5KZC4
SHANK3
ENST00000262795.8
TSL:5
c.-265C>T
5_prime_UTR_premature_start_codon_gain
Exon 1 of 21ENSP00000489147.3A0A0U1RQS4
SHANK3
ENST00000262795.8
TSL:5
c.-265C>T
5_prime_UTR
Exon 1 of 21ENSP00000489147.3A0A0U1RQS4

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000359
AC:
5
AN:
1392588
Hom.:
0
Cov.:
31
AF XY:
0.00000582
AC XY:
4
AN XY:
687078
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31540
American (AMR)
AF:
0.00
AC:
0
AN:
35780
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25148
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35764
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79142
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44346
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4066
European-Non Finnish (NFE)
AF:
0.00000463
AC:
5
AN:
1079014
Other (OTH)
AF:
0.00
AC:
0
AN:
57788
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
16
DANN
Benign
0.96
PhyloP100
-1.8
PromoterAI
0.022
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs891780204; hg19: chr22-51113505; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.